 |  |
| PHIN2029-1 | Regulation and the medical-social environment - Legislation and procedures applied to pharmaceutical industry, part a : legislation - Legislation and procedures applied to pharmaceutical industry, part b : patents and protection - Economic and medical social medicine - CTD File (Common Technical Document) - Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files - Regulations of preclinical and clinical studies, part b : clinical studies - Regulations of preclinical and clinical studies, part c : pediatric studies - Specific regulatory issues, part a : medicine and herbal dietary supplement - Specific regulatory issues, part a : galenic developement
 |
 |
| Duration : | Legislation and procedures applied to pharmaceutical industry, part a : legislation : 10h Th, 5h Pr Legislation and procedures applied to pharmaceutical industry, part b : patents and protection : 5h Th Economic and medical social medicine : 10h Th CTD File (Common Technical Document) : 15h Th Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files : 15h Th Regulations of preclinical and clinical studies, part b : clinical studies : 5h Th Regulations of preclinical and clinical studies, part c : pediatric studies : 2,5h Th Specific regulatory issues, part a : medicine and herbal dietary supplement : 5h Th Specific regulatory issues, part a : galenic developement : 5h Th
|
 |
| Credits/ECTS : |
|
 |
| Holder(s) : | Legislation and procedures applied to pharmaceutical industry, part a : legislation : Catherine Druez
Legislation and procedures applied to pharmaceutical industry, part b : patents and protection : Sylvie Ponchaut
Economic and medical social medicine : Alain De Wever
CTD File (Common Technical Document) : Jean‑Antoine De Muylder
Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files : Sonia Beken
Regulations of preclinical and clinical studies, part b : clinical studies : A Lenaers
Regulations of preclinical and clinical studies, part c : pediatric studies : Daniel Brasseur
Specific regulatory issues, part a : medicine and herbal dietary supplement : Monique Tits
Specific regulatory issues, part a : galenic developement : Francis Vanderbist
|
 |
| Coordinator : | Philippe Hubert |
 |
| Language : | French language |
 |

|
|  |